These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37803082)

  • 41. Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example.
    Wagner AC; Mithoefer MC; Mithoefer AT; Monson CM
    J Psychoactive Drugs; 2019; 51(2):166-173. PubMed ID: 30890035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expectancy Effects Cannot Be Neglected in MDMA-Assisted Therapy Research.
    Flameling LJ; Aday JS; van Elk M
    ACS Chem Neurosci; 2023 Dec; 14(23):4062-4063. PubMed ID: 37967550
    [No Abstract]   [Full Text] [Related]  

  • 43. Stressing the possibilities.
    Shrubb R
    Ment Health Today; 2013; ():12-3. PubMed ID: 24354215
    [No Abstract]   [Full Text] [Related]  

  • 44. Can MDMA play a role in the treatment of substance abuse?
    Jerome L; Schuster S; Yazar-Klosinski BB
    Curr Drug Abuse Rev; 2013 Mar; 6(1):54-62. PubMed ID: 23627786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.
    Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ
    J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.
    Nogrady B
    BMJ; 2023 Jul; 382():1599. PubMed ID: 37433614
    [No Abstract]   [Full Text] [Related]  

  • 47. MDMA-assisted psychotherapy for the treatment of PTSD.
    Reiff CM; McDonald WM
    Braz J Psychiatry; 2021; 43(2):123-124. PubMed ID: 33053043
    [No Abstract]   [Full Text] [Related]  

  • 48. Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.
    Haridy R
    Nature; 2023 Jul; 619(7969):227-228. PubMed ID: 37386185
    [No Abstract]   [Full Text] [Related]  

  • 49. Psilocybin and MDMA for the treatment of trauma-related psychopathology.
    Bird CIV; Modlin NL; Rucker JJH
    Int Rev Psychiatry; 2021 May; 33(3):229-249. PubMed ID: 34121583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychotherapy-supported MDMA treatment for PTSD.
    Krystal JH; Kelmendi B; Petrakis IL
    Cell Rep Med; 2021 Aug; 2(8):100378. PubMed ID: 34467253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy.
    Amoroso T; Workman M
    J Psychopharmacol; 2016 Jul; 30(7):595-600. PubMed ID: 27118529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Making a medicine out of MDMA.
    Sessa B; Nutt D
    Br J Psychiatry; 2015 Jan; 206(1):4-6. PubMed ID: 25561485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail.
    Bedi G; Cotton SM; Guerin AA; Jackson HJ
    Aust N Z J Psychiatry; 2023 Apr; 57(4):476-481. PubMed ID: 36165006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD.
    Barone W; Beck J; Mitsunaga-Whitten M; Perl P
    J Psychoactive Drugs; 2019; 51(2):199-208. PubMed ID: 30849288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can ecstasy treat the agony of PTSD?
    Kupferschmidt K
    Science; 2014 Jul; 345(6192):22-3. PubMed ID: 24994631
    [No Abstract]   [Full Text] [Related]  

  • 56. Psychedelic drugs-a new era in
psychiatry?
.
    Nutt D
    Dialogues Clin Neurosci; 2019; 21(2):139-147. PubMed ID: 31636488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence, Neurobiological Plausibility, and Clinical Significance.
    Price CM; Feduccia AA; DeBonis K
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):464-469. PubMed ID: 36018231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment.
    Vermetten E; Yehuda R
    Neuropsychopharmacology; 2020 Jan; 45(1):231-232. PubMed ID: 31455855
    [No Abstract]   [Full Text] [Related]  

  • 59. Psychedelic drugs: the ups and downs of ecstasy.
    Check E
    Nature; 2004 May; 429(6988):126-8. PubMed ID: 15141183
    [No Abstract]   [Full Text] [Related]  

  • 60. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].
    Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J
    Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.